Public Profile

Krka

Krka, d.d., a prominent pharmaceutical company headquartered in Slovenia (SI), has established itself as a leader in the global healthcare industry since its founding in 1946. With a strong presence in Europe and beyond, Krka focuses on the development, production, and marketing of prescription pharmaceuticals, over-the-counter products, and animal health medications. Renowned for its commitment to quality and innovation, Krka offers a diverse range of products, including generic medicines and proprietary brands, which are distinguished by their efficacy and affordability. The company has achieved significant milestones, including numerous awards for its research and development efforts, solidifying its position in the competitive pharmaceutical landscape. With a robust market presence and a dedication to sustainability, Krka continues to contribute to the advancement of healthcare worldwide.

DitchCarbon Score

How does Krka's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Krka's score of 25 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Krka's reported carbon emissions

In 2022, Krka reported total carbon emissions of approximately 79,880,000 kg CO2e for Scope 1 and about 57,059,000 kg CO2e for Scope 2. This reflects a significant commitment to monitoring and managing their carbon footprint, although no data is available for Scope 3 emissions. Over the years, Krka's emissions have fluctuated, with Scope 1 emissions peaking at about 143,292,000 kg CO2e in 2020 and Scope 2 emissions reaching approximately 72,684,000 kg CO2e in 2019. The company has not set specific reduction targets or climate pledges, indicating a potential area for future commitment. Krka's emissions data highlights their ongoing efforts to address climate change, but the absence of defined reduction initiatives suggests that further action may be necessary to align with industry standards and expectations for sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201720182019202020212022
Scope 1
33,603,000
00,000,000
00,000,000
000,000,000
000,000,000
00,000,000
Scope 2
43,761,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Krka's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Krka is in SI, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Krka is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Apontis Pharma AG

DE
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Akorn

US
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Zao Ranbaxy, Russia

RU
Updated 3 months ago
DitchCarbon Score

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

STADA Arzneimittel Aktiengesellschaft

DE
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Berlin-Chemie/Menarini Pharma GmbH

DE
Other business services (74)
Updated 3 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers